文献速递瓣膜外科先天性心脏病外科

当代Ross手术的中远期结果:214例患者分析

Contemporary Ross procedure outcomes: medium- to long-term results in 214 patients.
PubMed 文献 · Eur J Cardiothorac Surg · 2021-01-01

单中心回顾性分析1997—2019年214例Ross手术患者,比较两个时代的技术改良效果。避免自体移植物再手术的10年与20年自由率分别为87%和69%,两时代间无显著差异。结论认为当代改良Ross手术结果优异,应继续作为儿童和年轻成人主动脉瓣替代策略的一部分。

要点

  • 避免自体移植物再手术的10年与20年自由率分别为87%和69%,两时代间无显著差异。
  • 主动脉瓣反流、感染性心内膜炎和era 1是自体移植物再手术的预测因素。

核心结论

  • 当代改良Ross手术持续提供优异结果,应继续作为需要主动脉瓣替代的儿童和年轻成人的治疗策略之一。

研究设计与样本

  • 单中心回顾性研究,纳入1997至2019年共214例Ross手术患者,比较era 1(1997-2009)与era 2(2010-2019)两个时代。

主要发现

  • 避免大于中度主动脉瓣反流或主动脉瓣干预的10年与20年自由率分别为91%和80%。
  • 93%的患者处于NYHA功能I级。
  • era 1有20例(21%)患者、era 2有6例(9%)患者接受自体移植物再手术。
  • 避免自体移植物再手术的10年与20年自由率分别为87%和69%,两时代间无显著差异。

临床怎么用

  • 对于需要主动脉瓣替代的儿童和年轻成人,当代改良Ross手术可作为治疗策略的一部分。

局限性

  • 本研究为单中心回顾性分析,结果可能受中心经验和患者选择影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Our goal was to present 2 decades of our experience with the Ross procedure and its sequential modifications, adopted since 2010, to improve the reoperation rate. METHODS: We performed a single-centre, retrospective review of database information and medical notes about the implantation technique: the freestanding root. We compared era 1 (1997-2009) and era 2 (2010-2019). RESULTS: Between 1997 and 2019, a total of 214 Ross procedures were performed (71% men, median age 24 years) [interquartile range (IQR) 15-38]. Of these, 87% had various forms of congenital-dysplastic aortic valves. The median cross-clamping and bypass times were 173 (IQR 148-202) and 202 (IQR 182-244) min. The median postoperative stay was 6 days (2-77). Thirty-day mortality was 0.5%. The median follow-up time was 8.2 years (IQR 3.9-13.2). Survival at 10 and 20 years was 97% and 95%; freedom from greater than moderate aortic regurgitation or aortic valve intervention was 91% and 80%; and 93% of the patients were in New York Heart Association functional class I. Twenty (21%) patients operated on during era 1 and 6 (9%) during era 2 underwent autograft reoperations. The median follow-up time was 14.3 (IQR 11.5-17.4) and 4.8 (IQR 2.5-7) years. Freedom from autograft reoperation was 87% and 69% at 10 and 20 years, with no significant difference between eras. Freedom from homograft reoperation was 96% and 76% at 10 and 20 years. The presence of aortic regurgitation, infective endocarditis and era 1 were predictors of autograft reoperation. Male gender and era 1 were predictors of neoaortic root dilatation. CONCLUSIONS: The contemporary modified Ross procedure continues to deliver excellent results and should remain part of the strategy to treat children and young adults requiring aortic valve replacement.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Generali T, Jansen K, Steedman R, et al. Contemporary Ross procedure outcomes: medium- to long-term results in 214 patients. Eur J Cardiothorac Surg. 2021. PMID: 33969415. doi:10.1093/ejcts/ezab193

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。